l-carnitine tmao koeth 2013 nature medicine γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of to JCI - l-Carnitine in omnivorous
JCI l Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans Frontiers TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review The gutbrain axis and trimethylamine N oxide: an emergent biomarker in neurological diseases ScienceDirect TMAO metaorganismal pathway and chronic inflammatory diseases
Pay in 4 interest-free payments of $5.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



